WallStreetZenWallStreetZen

NYSE: STVN
Stevanato Group Spa Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

STVN past earnings growth

How has STVN's earnings growth performed historically?
Company
6.45%
Industry
27.28%
Market
62.15%
STVN's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
STVN's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
STVN's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

STVN past revenue growth

How has STVN's revenue growth performed historically?
Company
15.24%
Industry
7.74%
Market
17.33%
STVN's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
STVN's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
STVN's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

STVN earnings and revenue history

Current Revenue
$1.2B
Current Earnings
$161.8M
Current Profit Margin
13.4%

STVN Return on Equity

Current Company
13.5%
Current Industry
11.1%
Current Market
188%
STVN's Return on Equity (13.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when STVN announces earnings.

STVN Return on Assets

Current Company
7.7%
Current Industry
7.2%
STVN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

STVN Return on Capital Employed

Current Company
14.76%
Current Industry
9.7%
STVN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

STVN vs Medical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
STVN$1.18B$325.43M$158.29M+18.93%+35.74%
ATR$3.49B$664.15M$284.49M+4.75%+6.82%
RGEN$638.76M$134.17M$41.58M+26.91%+14.57%
XRAY$3.97B$249.00M-$132.00M-0.11%N/A
TFX$2.97B$759.97M$356.33M+3.97%+11.54%
View Top Medical Stocks

Stevanato Group Spa Earnings & Revenue FAQ

What were STVN's earnings last quarter?

On Invalid Date, Stevanato Group Spa (NYSE: STVN) reported Q4 2023 earnings per share (EPS) of $0.19, up 1.05% year over year. Total Stevanato Group Spa earnings for the quarter were $50.26 million. In the same quarter last year, Stevanato Group Spa's earnings per share (EPS) was $0.19.

If you're new to stock investing, here's how to buy Stevanato Group Spa stock.

What was STVN's earnings growth in the past year?

As of Q2 2024, Stevanato Group Spa's earnings has grown 6.45% year over year. This is 20.84 percentage points lower than the US Medical Instruments & Supplies industry earnings growth rate of 27.28%. Stevanato Group Spa's earnings in the past year totalled $158.29 million.

What was STVN's revenue last quarter?

On Invalid Date, Stevanato Group Spa (NYSE: STVN) reported Q4 2023 revenue of $356.27 million up 14.65% year over year. In the same quarter last year, Stevanato Group Spa's revenue was $310.74 million.

What was STVN's revenue growth in the past year?

As of Q2 2024, Stevanato Group Spa's revenue has grown 15.24% year over year. This is 7.5 percentage points higher than the US Medical Instruments & Supplies industry revenue growth rate of 7.74%. Stevanato Group Spa's revenue in the past year totalled $1.18 billion.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.